Motor Learning in Gait in Subjects With Diabetic Peripheral Neuropathy
NCT ID: NCT00223782
Last Updated: 2008-03-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
150 participants
INTERVENTIONAL
2004-05-31
2006-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Comparisons: Two groups of subjects will receive gait training, one group will receive feedback of performance while the other will only receive training, and one control group. Comparisons will include whether plantar pressures are decreased in the training groups, and if those changes are maintained long-term.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Gait Training with Feedback
Gait Training with no feedback
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Gait Training with Feedback
Gait Training with no feedback
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Diabetic peripheral neuropathy as defined by failure to sense the 5.07 (10g) monofilament test in one or more of the six sites tested (31;32)
3. Age 50-80 years old
4. Able to ambulate independently without assistive devices (e.g. walker or crutches) (8) for 30 feet.
5. No evidence of neurological (other than peripheral neuropathy) or orthopedic conditions
Exclusion Criteria
2. Symptomatic peripheral vascular disease
3. Joint pain, swelling and/or limited of range of motion in the lower extremities that interfere with walking or exercise
4. Visual problems not correctable with glasses or contact lens
5. Passive range of motion limitations are described as:
1. Hip flexion \< 1000;
2. Hip extension \< 200;
3. Knee flexion \< 1250;
4. Knee extension \< 00 (unable to obtain full extension);
5. Ankle plantar flexion \< 250;
6. Ankle dorsiflexion \< 150
6. Other systemic or local diseases that could interfere with walking assessment
7. Severe systemic diseases other than diabetes or its complications, especially those interfering with exercise tolerance
8. Amputation in the lower extremities
9. Terminal illness
10. Severe obesity: BMI\>30 kg/m2 (33)
11. Severe foot deformities (e.g. flexion contracture of the toes, pes cavus, Charcot disease)
12. Mini-mental status of \<27 or diagnosis of dementia
13. History of alcohol or drug abuse
50 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
US Department of Veterans Affairs
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Department of Veterans Affairs
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Karen Perell, PhD RKT
Role: PRINCIPAL_INVESTIGATOR
VA Greater Los Angeles Healthcare System, West LA
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VA Greater Los Angeles Healthcare System, West LA
West Los Angeles, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A3117R
Identifier Type: -
Identifier Source: org_study_id